| Formulary Chapter 2: Cardiovascular system - Full Chapter
|
| Chapter Links... |
 Cardiology guidelines (NICE) |
 Heart failure traffic lights - Nottinghamshire management of heart failure patients |
| UKMI: MI - secondary prevention - Summary of NICE guidance (CG172) |
| Details... |
| 02.11 |
Antifibrinolytic drugs and haemostatics |
|
|
| 02.11 |
Blood-related products |
|
|
Albutrepenonacog alfa (Idelvion®)
|
 Restricted
|
Non pharmacy item, please contact blood bank for details and availability
|
|
|
Antithrombin III (Kybernin®)
|
Restricted
|
Non pharmacy item please contact blood bank for details and availability.
|
|
|
Efmoroctocog alfa (Elocta®)
|
Restricted
|
Non pharmacy item please contact blood bank for details and availability
Available through homecare for NUH patients. Please contact pharmacy medicines homecare team for further information
|
|
|
Eftrenonacog alfa (Alprolix®)
|
Restricted
|
Non pharmacy item, please contact blood bank for details and availability.
Available through homecare for NUH patients. Please contact pharmacy medicines homecare team for further information
|
|
|
Emicizumab (Hemlibra®)
|
Restricted
|
Injection
Available at NUH only:
- Approved in accordance with the Clinical Commissioning Policy for the prophylaxis in people with cogential haemophilia A with factor VIII inhibitors (all ages).
- Approved in accordance with the Clinical Commissioning Policy for the prophylaxis in people with severe cogential haemophilia A without factor VIII inhibitors (all ages).
Available through homecare for NUH patients. Please contact pharmacy medicines homecare team for further information.
|
|
|
Factor Eight Inhibitor Bypassing Fraction (Feiba®)
|
Restricted
|
Non pharmacy item, please contact blood bank for details and availability
Available through homecare for NUH patients. Please contact pharmacy medicines homecare team for further information
|
|
|
Factor VIIa (Recombinant), Eptacog alfa (NovoSeven®)
|
Restricted
|
Non pharmacy item please contact blood bank for details and availability.
- At SFH, one dose is stocked in blood bank. In the event of further doses being required (consultant haematologist request only), contact pharmacy (or on call pharmacist out of hours). See memo for further details.
- Available through homecare for NUH patients. Please contact pharmacy medicines homecare team for further information
|
|
|
Factor VIII (NovoEight®)
|
Restricted
|
Non pharmacy item, please contact blood bank for details and availability
Available through homecare for NUH patients. Please contact pharmacy medicines homecare team for further information
|
|
|
Factor VIII - Von willebrand factor (Type 8Y®)
|
Restricted
|
Non pharmacy item, please contact blood bank for details and availability
|
|
|
Factor VIII - Von willebrand factor (Wilate®)
|
Restricted
|
Non pharmacy item, please contact blood bank for details and availability
|
|
|
Factor VIII + von Willebrand factor (Voncento®)
|
Restricted
|
Factor VIII, von willebrand factor - NUH only
Non pharmacy item please contact blood bank for details and availability
Available through homecare for NUH patients. Please contact pharmacy medicines homecare team for further information
|
|
|
Human Fibrinogen (Riastap®)
|
Restricted
|
Non pharmacy item, please contact blood bank for details and availability
Available through homecare for NUH patients. Please contact pharmacy medicines homecare team for further information
|
|
|
Moroctocog alfa (Refacto®)
|
Restricted
|
Non pharmacy item, please contact blood bank for details and availability
Available through homecare for NUH patients. Please contact pharmacy medicines homecare team for further information
|
|
|
Nonacog alfa (BeneFIX®)
|
Restricted
|
Non pharmacy item, please contact blood bank for details and availability
Available through homecare for NUH patients. Please contact pharmacy medicines homecare team for further information
|
|
|
Octocog alfa (Advate®)
|
Restricted
|
Non pharmacy item, please contact blood bank for details and availability
Available through homecare for NUH patients. Please contact pharmacy medicines homecare team for further information
|
|
|
Octocog alfa (Kogenate®)
|
Restricted
|
Non pharmacy item, please contact blood bank for details and availability
|
|
|
Protein C Concentrate (Ceprotin®)
|
Restricted
|
Non pharmacy item please contact blood bank for details and availability.
|
|
|
Prothrombin Complex Concentrate (Octaplex®)
|
Restricted
|
SFH: Pharmacy to order in for pathology to keep as stock
Non pharmacy item please contact blood bank for details and availability.
|
(SFH) Octaplex administration guide
Manufacturers data sheet (SPC)
|
Simoctocog alfa (Nuwiq®)
|
Restricted
|
Recombinant Factor VIII Product - NUH only
Non pharmacy item please contact blood bank for details and availability
Available through homecare for NUH patients. Please contact pharmacy medicines homecare team for further information
|
|
|
Susoctocog alfa (Obizur®)
|
Restricted
|
Injection
Approved in accordance with the Clinical Commissioning Policy for use in treating bleeding episodes in people with acquired haemophilia A (all ages).
Non pharmacy item, please contact haemophilia unit for details and availability.
|
|
|
Von willebrand factor (Willfact®)
|
Restricted
|
Non pharmacy item, please contact blood bank for details and availability
|
|
|
| .... |
| Non Formulary Items |
Drotrecogin Alfa (Activated) (Xigris®)
|
Non Formulary
|
Marketing authorisation withdrawn October 2011 |
Link to reviews
|
Factor IX Fraction, Dried
|
Non Formulary
|
|
|
|
Factor VIII Fraction, Dried
|
Non Formulary
|
|
|
|
Factor VIII Inhibitor Bypassing Fraction
|
Non Formulary
|
|
|
|
Factor XIII Fraction, Dried
|
Non Formulary
|
|
|
|
Fresh Frozen Plasma
|
Non Formulary
|
|
|
|
Human Coagulation Factor X (Coagadex®)
|
Non Formulary
|
Injection
- Not recommended in the NHS England Clinical Commissioning Policy
|
Clinical Commissioning Policy: Human coagulation factor X for hereditary factor X deficiency (all ages)
|
Human fibrinogen & thrombin (Raplixa® )
|
Non Formulary
|
No formal submission (APC May 15) |
|
|
| |
Key |
|
|
|
|
Cytotoxic Drug
|
|
|
Controlled Drug
|
|
High Cost Medicine
|
|
Cancer Drugs Fund
|
|
NHS England |
|
Homecare |
|
CCG |
|
Traffic Light Status Information
| Status |
Description |
|
Grey / Non-Formulary: Medicines, which the Nottinghamshire APC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data.
Grey / Non-Formulary (undergoing assessment): Work is ongoing and will be reviewed at a future APC meeting.
Grey / Non-Formulary (no formal assessment): APC has not formally reviewed this medicine or indication because it had never been requested for formulary inclusion. Often used for drugs new to market.
|
|
Medicines which should normally be prescribed by specialists only. eg hospital only.
For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care.
|
|
Medicines that should be initiated by a specialist and prescribed by primary care prescribers only under a shared care protocol, once the patient has been stabilised.
Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the Nottinghamshire APC.
|
|
Medicines suitable to be prescribed in primary care / general practice after specialist* recommendation or initiation.
A supporting prescribing guideline may be requested which must have been agreed by the relevant secondary care trust DTCs and approved by the Nottinghamshire APC.
*Specialist is defined by the APC as a clinician who has undertaken an appropriate formal qualification or recognised training programme within the described area of practice
|
|
Primary care/ non specialist may initiate as per APC guideline.
The supporting prescribing guideline must have been agreed by the relevant secondary care trust D&TC(s) and approved by the Nottinghamshire APC.
|
|
Medicines suitable for routine use within primary care.
Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing. |
|
|
|
|
|
